Prevention of infections and other complications after splenectomy;Prävention von Infektionen und Thrombosen nach Splenektomie oder bei Funktionsverlust der Milz

Deutsche Medizinische Wochenschrift

Volumn 134, Issue 17, 2009, Pages 897-902

  Engelhardt, M ^a   Haas, P S ^a   Theilacker, C ^a   Eber, S W ^b   Schmugge, M ^c   Kern, W V ^a   Heimpel, H ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Kinderspital Zürich ^*  (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Antibiotic prophylaxis; Infections; Splenectomy; Vaccination

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ASPLENIA; HODGKIN DISEASE; HUMAN; INFECTION PREVENTION; POSTOPERATIVE COMPLICATION; REVIEW; SEPSIS; SPLENECTOMY; VACCINATION; BACTERIAL INFECTION; IMMUNOLOGY; INFLUENZA; INJURY; MALARIA; PATHOPHYSIOLOGY; RISK FACTOR; SPLEEN; SPLEEN DISEASE; THROMBOSIS;

BACTERIAL VACCINE; INFLUENZA VACCINE;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BACTERIAL VACCINES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALARIA; RISK FACTORS; SPLEEN; SPLENECTOMY; SPLENIC DISEASES; THROMBOSIS;

EID: 64749098130     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1220231     Document Type: Review

References (42)

1. Agre P, Asimos A, Casella JF, McMillan C. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 1986; 315: 1579-1583
2. Balmer P, Falconer M, McDonald P et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun 2004; 72: 332-337
3. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43: 182-186
4. Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ. General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 2004; 126: 455-474
5. Cherif H, Landgren 0, Konradsen HB, Kalin M, Bjorkholm M. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcalinfection in splenectomized patients with haematological diseases. Vaccine 2006; 24: 75-81
6. Corbett SM, Rebuck JA, Rogers FB et al. Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy. J Trauma 2007; 62: 397-403
7. Cullingford GL, Watkins DN, Watts AD, Mallon DF. Severe late post-splenectomy infection. Br J Surg 1991; 78: 716-721
8. Cumbria & Lancashire Health Protection Unit NHS Splenectomy Guidelines June 2002: Guidance on the Prevention of Infections in Asplenic Patients or Patients with a Dysfunctional Spleen, http://www.healthprotection. org.uk/
9. Dickerhoff R, Mahlberg R. Sichelzellkrankheiten Leitlinie der DGHO: Sichelzellkrankheit. April 2005
10. Diem H, Heimpel H, Thomalla J. Leitlinie der DGHO: Anämie Anämien. November 2007
11. Eber SW, Langendörfer CM, Ditzig M et al. Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: impact of insufficient antibody response to pneumococcal infection. Ann Hematol 1999; 78: 524-528
12. Ejstrud P, Kristensen B, Hansen JB, Madsen KM, Schonheyder HC, Sorensen HT. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis 2000; 32: 521-525
13. Evans DI. Postsplenectomy sepsis 10 years or more after operation. J Clin Pathol 1985; 38: 309-311
14. George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40
15. Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001; 4: 105-121
16. Heiniger U. Prävention schwerer Infektionen bei anatomischer oder funktioneller Asplenie. BAG-Builletin 2006; 49: 977-983www.bag.admin.ch/ dokumentation/publikationen
17. Holdsworth R, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78: 1031-1038
18. Kotsanas D, Al-Souffi MH, Waxman BP, King RW, Polkinghome KR, Woolley IJ. Adherence to guidelines for prevention of postsplenectomy sepsis. Age and sex are risk factors: a five-year retrospective review. ANZ J Surg 2006; 76: 542-547
19. Kruetzmann S, Rosado MM, Weber H et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197: 939-945
20. Kyaw MH, Holmes EM, Toolis F et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006; 110: 276el-276e7
21. Kyaw M, Lynfield HR, Schaffner E et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354: 1455-1463
22. Mamani-Matsuda M, Cosma A, Weller S et al. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 2008; 111: 4653-4659
23. McVernon J, Howard AJ, Slack MP, Ramsay ME. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect 2004; 132: 765-767
24. McVernon J, Trotter CL, Slack MP, Ramsay ME. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 2004; 329: 655-658
25. Molrine DC, Antin JH, Guinan EC et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831-836
26. Molrine DC, Guinan EC, Antin JH et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012-3018
27. Musher DM, Ceasar H, Kojic EM et al. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 2005; 191: 1063-1067
28. Musher DM, Rueda AM, Nahm MH, Graviss EA, Rodriguez-Barradas MC. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. J Infect Dis 2008; 198: 1019-1027
29. Pietrabissa A, Moretto C, Antonelli G, Morelli L, Marciano E, Mosca F. Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc 2004; 18: 1140-1143
30. Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998; 11: 1-26
31. Riddington C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev, 2002CD003427
32. Robbins JB, Schneerson R. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D. N Engl J Med 1990; 323: 1415-1416
33. Rutherford EJ, Livengood J, Higginbotham M et al. Efficacy and safety of pneumococcal revaccination after splenectomy for trauma. J Trauma 1995; 39: 448-452
34. Seymour JF, Cusack JD, Lerner SA, Pollock RE, Keating MJ. Case/control study of the role of splenectomy in chronic lymphocytic leukemia. J Clin Oncol 1997; 15: 52-60
35. Shatz DV, Schinsky MF, Pais LB, Romero-Steiner S, Kirton OC, Carlone GM. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998; 44: 760-765
36. Shatz DV. Vaccination considerations in the asplenic patient. Expert Rev Vaccines 2005; 4: 27-34
37. Stamou KM, Toutouzas KG, Kekis PB et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 2006; 141: 663-669
38. Stoehr GA, Rose MA, Eber SW, Heidemann K Schubert R, Zielen S. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis. Br J Haematol 2006; 132: 788-790
39. Stoehr GA, Sobh JN, Luecken J et al. Near-total splenectomy for hereditary spherocytosis: clinical prospects in relation to disease severity. Br J Haematol 2006; 132: 791-793
40. Sumaraju V, Smith LG, Smith SM. Infectious complications in asplenic hosts. Infect Dis Clin North Am 2001; 15: 551-565
41. Soyer T. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome. J Pediatr Surg 2006; 41: 1899-902 (Pubitemid 44709084)
42. Weiss M, Bartmann P, Belohradsky BH, Eber SW, Schulte-Wissermann H. Infektionsprophylaxe bei Asplenie. In: Scholz H, Belohradsky BH, Heininger U, Kreth W, Roos R (Hrsg). Handbuch: Infektionen bei Kindern u. Jugendlichen. (Mit Modifikationen). 5. Aufl. Dtsch Ges pädiatr Infektiol, (Futuramed im Druck).